Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  ONO PHARMACEUTICAL CO., LTD.    4528   JP3197600004

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials (JPY)
Sales 2019 276 B
EBIT 2019 -
Net income 2019 51 376 M
Finance 2019 104 B
Yield 2019 1,75%
Sales 2020 310 B
EBIT 2020 -
Net income 2020 65 224 M
Finance 2020 124 B
Yield 2020 1,87%
P/E ratio 2019 27,65
P/E ratio 2020 21,61
EV / Sales2019 5,00x
EV / Sales2020 4,39x
Capitalization 1 485 B
More Financials
Company
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine.The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan. 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of ONO PHARMACEUTICAL CO., LT
Trading Rating : Investor Rating :
More Ratings
Latest news on ONO PHARMACEUTICAL CO., LT
05/07ONO PHARMACEUTICAL : European Medicines Agency Validates Bristol-Myers Squibb&rs..
PU
05/07ONO PHARMACEUTICAL : Karyopharm Announces Positive Top-Line Data from Phase 2b S..
PU
04/26ONO PHARMACEUTICAL : Submits an Application for Manufacturing and Marketing Appr..
PU
04/25Shire bid marks Takeda's latest - and biggest - push for global status
RE
04/25ONO PHARMACEUTICAL : Submits Applications for Manufacturing and Marketing Approv..
PU
04/19ONO PHARMACEUTICAL : U.S. Food and Drug Administration Accepts Supplemental Biol..
PU
04/18ONO PHARMACEUTICAL : U.S. Food and Drug Administration Approves Opdivo® (nivolum..
PU
04/17ONO PHARMACEUTICAL : Opdivo Plus Low-Dose Yervoy Combination Reduces the Risk of..
PU
04/17ONO PHARMACEUTICAL : In CheckMate -141, Opdivo (nivolumab) Demonstrated Sustaine..
PU
04/16ONO PHARMACEUTICAL : Opdivo (nivolumab), First PD-1 Inhibitor to Demonstrate Sup..
PU
More news
Sector news : Generic Pharmaceuticals
05/21MERCK AND : Ebola Vaccination Begins in Democratic Republic of Congo -- Update
DJ
05/21MERCK AND : Factbox - From sterling crises to Brexit, the tests of Bank of Engla..
RE
05/21ASTRAZENECA : potassium drug finally approved, threatening Vifor
RE
05/21EU Approves GlaxoSmithKline JV's Juluca HIV Treatment
DJ
05/21MERCK AND : Ebola Vaccine Arrives in Democratic Republic of Congo
DJ
More sector news : Generic Pharmaceuticals
Latest Tweets
05/07ONO PHARMACEUTICAL : Karyopharm Announces Positive Top-Line Data from Phase 2.. 
04/19ONO PHARMACEUTICAL : U.S. Food and Drug Administration Accepts Supplemental B.. 
04/18ONO PHARMACEUTICAL : U.S. Food and Drug Administration Approves Opdivo® (nivo.. 
04/17ONO PHARMACEUTICAL : In CheckMate -141, Opdivo (nivolumab) Demonstrated Susta.. 
02/20Binimetinib (Array BioPharma/Pierre Fabre/Ono Pharmaceutical) Drug Analysis 2.. 
More tweets
Qtime:28
News from SeekingAlpha
04/303 THINGS IN BIOTECH, APRIL 29 : Bristol-Myers Widens, Ono Takes On Pheo, BrainSt.. 
03/23Alzheon Files To Raise $80 Million In U.S. IPO 
03/14Ono Pharma exercises option for Merus Biclonics technology for autoimmune bis.. 
2017Ono Pharmaceutical Needs To Reinvest Its Windfall 
2017YOUR DAILY PHARMA SCOOP : Axovant's Promised Upside, Gilead's Whistleblower Trou.. 
Chart ONO PHARMACEUTICAL CO., LT
Duration : Period :
ONO PHARMACEUTICAL CO., LT Technical Analysis Chart | 4528 | JP3197600004 | 4-Traders
Technical analysis trends ONO PHARMACEUTICAL CO., LT
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 3 213  JPY
Spread / Average Target 18%
EPS Revisions
Managers
NameTitle
Gyo Sagara President & Representative Director
Kazuhito Kawabata Director & Managing Executive Officer
Hiroshi Awata Director & Executive Vice President
Isao Ono Director & Managing Executive Officer
Kei Sano Director & Senior Executive Officer